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!  Lidocaine used as pain reliever on ISS 
!  Bovine Serum Albumin (BSA) 
" Identical to that found in human blood 
" 2nd most common     
 protein in blood 
" Binding either through    
 hydrophobic or      
 electrostatic forces 
Image: S.W. Sarsam, D.R. Nutt, K. Strohfeldt, and K.A. 
Watson, 2011. Titanocene anticancer complexes and their 
binding mode of action to human serum albumin: A 
computational study. Metallomics,3, 152-161 
!  Manned-mission to Mars in     2030’s 
will need stable          
pharmaceuticals 
!  We need to determine how stable Lidocaine is 
under different stresses (pH, temperature, gamma 
radiation, UV light) 
" Does it degrade? 
!  What changes are there in binding to BSA 
" This will affect drug delivery throughout the body 
Image: Astrobites.org 
!  Topical Lidocaine very viscous 
" Preparing solutions not 
accurate 
!  Precipitate point inconsistent 
!  2+ years past expiration 
Top Image: abc.net.au 
NEXT STEPS: 
USE 
AQUEOUS 2% 
SOLUTION 
CONTAINING 
ADDITIVES 
!  Measures absorbance of solutions at different 
wavelengths 
!  Peaks correspond to specific electron transitions 
!  Unique spectra based  
 on chemical bonds of 
 compound 
!  Good for liquid solutions 
!  Can be used to           
determine concentration 
!  Previous research       
provided references 
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Shows the pH dependence of Lidocaine solutions with 
additives at concentration of 0.2mg/mL. Peak at 255nm is 
present for pH < 8 and peak at 295nm appears for pH > 7 
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Comparison of Radiated and  
Non-radiated Lidocaine 
non-radiated 
radiated 25Gy 
Lidocaine with additives was radiated with Cesium-137 
(gamma radition). No change in spectrum was observed. 
!  Peaks for our solutions occurred 
 at 255nm (when acidic) and  
 295nm (when basic) 
" Literature says absorbance peak at 263nm 
" Lidocaine precipitated from 2% aqueous has 
different spectra than diluted solution and 
matches literature 
" When exposed to UV light, solution appeared 
VERY yellow but no change in UV spectra 
Image: amandavyne.com 
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Comparing Different Lidocaine 
Formulations with Same 
Concentration  
Lidocaine Without 
Additives 
Lidocaine with 
Additives 
Both solutions are at 0.2mg/mL and pH 7 in 20mM Sodium 
Phosphate buffer. Peak for additive formula at 255nm but 
non-additive formula at 263nm 
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Absorbance of Lidocaine 
Solution Without Additives 
pH4 
pH6 
pH7 
pH8 
pH9 
Prepared with 20mM buffer solutions: Sodium Acetate 
(pH4), Sodium Phosphate (pH6-8) & Glycine (pH9). 
Extinction coefficient was found to be 1.66mL/mg*cm 
y = 1.6646x - 0.027 
R² = 0.99938 
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Determining 
Extinction Coefficient 
of Lidocaine 
0.0 
1.0 
2.0 
3.0 
240 260 280 300 320 340 
A
bs
or
ba
nc
e 
Wavelength (nm) 
Comparison Between Native 
and 74 Hour UVC Exposed 
Lidocaine Native 
Lidocaine 
UVC 
Exposed 
Lidocaine 
Small amount of evaporation occurred, so concentration 
increased. Appeared faint yellow, but no new peaks present, 
so little to no degradation assumed to have happened 
Use Dialysis Bags  
! Lidocaine=234Da 
compared to 
BSA=66kDa 
! Lidocaine in 
excess to BSA 
! Because of size, 
unbound 
Lidocaine able to 
leave bag (red 
dots in diagram)  Image:ehumanbiofield.wikispaces.com 
!  Changes in specific heat capacity can indicate 
changes in chemical structure and/or binding 
between BSA and Lidocaine 
!  Identify type of structure  
 of Lidocaine and BSA 
 by sharpness of peak 
!  Identify temperature of 
 denaturation for BSA,  
 Lidocaine and complex 
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Lidocaine 
Supernatant 
1st scan 
2nd scan 
Left (at pH9): Sharp peak at 48°C indicates presence of 
crystalline structure that dissolved and was no longer present 
in second scan or supernatant.  
Right (at pH7): Introduces possibility of third peak (above 
100°C), unknown if it is contributed by Lidocaine or additives 
from 2% aqueous solutions.  
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Lidocaine Precipitate 
1st scan 
2nd scan 
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Interactions between Lidocaine and 
Serum Albumin 
BSA BSA + Lidocaine BSA+ Lidocaine (25Gy) 
Temperature denaturation at 50°C and 70°C. Slight decrease 
in Td for first peak indicating less stable, weaker interactions. 
Diagram indicates slightly more stable due to higher Td 
compared to Lidocaine alone.  
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Determining Reversibility of Serum 
Albumin and Lidocaine 
BSA + Lidocaine BSA + Lidocaine (2nd scan) 
BSA was added directly to Lidocaine and temperature of 
denaturation shifted 55°C and 65°C. Second scan shows 
complete degradation of BSA and dissolved Lidocaine 
!  Expected that when bound to BSA, complex is 
more stable and should have higher temperature of 
denaturation 
" BSA added directly to 2% Lidocaine, peaks are 
closer together indicating stronger interactions 
!  Can’t conclude if due to additives or Lidocaine 
!  Dialysis caused lower concentration of Lidocaine & 
additives and DSC did not account for unbound 
Lidocaine  
" Third peak around 130°C believed to be due to 
Lidocaine 
!  Lidocaine is extremely stable 
" No significant changes in UV spectra when 
exposed to high temperatures, changes in pH, 
gamma radiation and UV light.  
!  Formula matters! 
" Additives overlap with Lidocaine UV spectra, 
another method is needed to distinguish 
degraded compounds (Raman Spectroscopy or 
High Performance Liquid Chromatography) 
!  Binding between Lidocaine and BSA is very weak 
" Need DSC with higher temperature capability 
!  Dr. Yuri Griko, NASA Ames Research Center 
!  Dominic Pasquali and Hilda Ruiz 
" SFSU and Cal State East Bay, respectively  
!  Dr. Dean Filipowicz, United Veterinary 
Specialty & Emergency 
!  Becthel 2015  
!  Afshin Khan,  
 Washington State University 
Image: babysignlanguage.com 
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